DaVita Inc.
$193.40
+9.47 · +5.15% today
Market open · updated 12:44:26 PM ET
- High
- $182.00 4:25 AM
- Low
- $179.20 4:05 AM
Against the S&P 500 Price change through Oct 28, 2026
DVA+61.90%
S&P 500+13.26%
DVA+41.91%
S&P 500+12.41%
DVA+139.59%
S&P 500+88.06%
DVA+61.20%
S&P 500+68.51%
Key numbers
- Previous close
- $183.93
- Open
- $190.01
- Day's range
- $184.33 – $194.25
- 52-week range
- $101.00 – $247.49
- Volume
- 723,213
- Average volume
- 776,524
- Market value
- $12.3 billion
- Price to earnings
- 15.8last 12 months
- Earnings per share
- $13.08last 12 months
- Beta
- 0.80moves less than the market
- Dividend
- None
- 50-day average
- $180.83
- 200-day average
- $176.15
Thursday, Oct 29, 2026, after the close.
Analyst price targets and the full financials are in the terminal.
Who DaVita buys from and competes with From our value chain
DaVita in the news
- HeadlineWill DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?Zacks Investment Research · October 27, 2026 at 1:31 PM ET
- HeadlineDaVita Brings Preventive Health Screenings Into Communities to Help Identify Hidden Health RisksPRNewsWire · October 27, 2026 at 9:00 AM ET
- HeadlineDaVita HealthCare (DVA) Falls More Steeply Than Broader Market: What Investors Need to KnowZacks Investment Research · October 23, 2026 at 7:01 PM ET
- HeadlineDaVita Stock Gains 55.6% Year to Date: What's Behind the Rally?Zacks Investment Research · October 22, 2026 at 3:41 PM ET
- Market closeS&P 500 edges up, Dow jumps 1% as health care and small caps leadWiseView Research desk · October 20, 2026
- HeadlineDaVita Inc. Schedules 3rd Quarter 2026 Investor Conference CallPRNewsWire · October 19, 2026 at 5:37 PM ET
- HeadlineDaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney CarePRNewsWire · October 15, 2026 at 9:00 AM ET
- CongressJulie Johnson sold $1,001 - $15,000 of DVAHouse filing · disclosed Aug 6, 2026
Earnings
Next report: Thursday, Oct 29, 2026, after the close.
Congress trades in DVA
1 purchase and 3 sales in the latest 4 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Julie JohnsonHouse · D-Texas | Sale | $1,001 - $15,000 | Sep 23, 2025 | Aug 6, 2026 |
| Julie JohnsonHouse · D-Texas | Purchase | $1,001 - $15,000 | Sep 23, 2025 | Aug 6, 2026 |
| Julie JohnsonHouse · D-Texas | Sale | $1,001 - $15,000 | Sep 25, 2025 | Oct 8, 2025 |
| Ro KhannaHouse · D-California | Sale | $1,001 - $15,000 | Sep 5, 2025 | Oct 3, 2025 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About DaVita
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 78,000
- Headquarters
- Denver, Colorado
- Website
- davita.com
- Listed
- Oct 31, 1995
More medical - care facilities stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.